06 Dec 2023
The revolution coming to tricuspid valve treatment with the EVOQUE replacement system
Sponsored by Edwards Lifesciences
Summary
Marianna Adamo and Philipp Lurz summarize the results of the TRISCEND II randomized trial which addresses the question of transcatheter tricuspid replacement (using the EVOQUE system) vs OMT. Find out more about the key findings at 6 months and the relevance for your practice
This interview was filmed at PCR London Valves 2023: see more videos here.